Instruments of Transformative Governance: Product Development Partnerships for Neglected Diseases

    Research output: Contribution to conferencePaperResearchpeer-review

    Abstract

    Product Development Partnerships (PDPs) for neglected diseases bring different actors together aiming to provide accessible medicines for these complex diseases. Finding solutions requires advanced investments in R&D, expensive clinical trials, long medicine approval processes, and reliable drug production and distribution channels. PDPs aim at overcoming current market and government failures by pooling resources in the attempt to solve this global social challenge. Thus, PDPs are a case of instruments of transformative research and innovation, operating in a transnational governance context. They exhibit three novelties: they address strategic long-term problems in a holistic manner, set substantive output-oriented goals, and are implemented through new organizational structures. After characterizing the different types of current PDPs and the context in which they emerged, the paper examines in detail three cases of single- and multi-disease PDPs (DNDi, EVI, and MVI). The cases show that their functions have been evolving through time, as the PDPs are becoming more specialized and focused. Yet, their ability to mobilize the resources (funding, organizational, knowledge and legitimacy resources) to fulfill these functions depends largely on their capability as agents to adapt to changing opportunity structures.
    Product Development Partnerships (PDPs) for neglected diseases bring different actors together aiming to provide accessible medicines for these complex diseases. Finding solutions requires advanced investments in R&D, expensive clinical trials, long medicine approval processes, and reliable drug production and distribution channels. PDPs aim at overcoming current market and government failures by pooling resources in the attempt to solve this global social challenge. Thus, PDPs are a case of instruments of transformative research and innovation, operating in a transnational governance context. They exhibit three novelties: they address strategic long-term problems in a holistic manner, set substantive output-oriented goals, and are implemented through new organizational structures. After characterizing the different types of current PDPs and the context in which they emerged, the paper examines in detail three cases of single- and multi-disease PDPs (DNDi, EVI, and MVI). The cases show that their functions have been evolving through time, as the PDPs are becoming more specialized and focused. Yet, their ability to mobilize the resources (funding, organizational, knowledge and legitimacy resources) to fulfill these functions depends largely on their capability as agents to adapt to changing opportunity structures.

    Conference

    Conference3rd International Conference on Public Policy
    Number3
    LocationLee Kuan Yew School of Public Policy
    CountrySingapore
    Period28/06/201730/06/2017
    Internet address

    Cite this

    Borrás, S. (2017). Instruments of Transformative Governance: Product Development Partnerships for Neglected Diseases. Paper presented at 3rd International Conference on Public Policy, Singapore.
    Borrás, Susana. / Instruments of Transformative Governance : Product Development Partnerships for Neglected Diseases. Paper presented at 3rd International Conference on Public Policy, Singapore.20 p.
    @conference{26bdde77c3204620ad2cde3fda366434,
    title = "Instruments of Transformative Governance: Product Development Partnerships for Neglected Diseases",
    abstract = "Product Development Partnerships (PDPs) for neglected diseases bring different actors together aiming to provide accessible medicines for these complex diseases. Finding solutions requires advanced investments in R&D, expensive clinical trials, long medicine approval processes, and reliable drug production and distribution channels. PDPs aim at overcoming current market and government failures by pooling resources in the attempt to solve this global social challenge. Thus, PDPs are a case of instruments of transformative research and innovation, operating in a transnational governance context. They exhibit three novelties: they address strategic long-term problems in a holistic manner, set substantive output-oriented goals, and are implemented through new organizational structures. After characterizing the different types of current PDPs and the context in which they emerged, the paper examines in detail three cases of single- and multi-disease PDPs (DNDi, EVI, and MVI). The cases show that their functions have been evolving through time, as the PDPs are becoming more specialized and focused. Yet, their ability to mobilize the resources (funding, organizational, knowledge and legitimacy resources) to fulfill these functions depends largely on their capability as agents to adapt to changing opportunity structures.",
    author = "Susana Borr{\'a}s",
    year = "2017",
    language = "English",
    note = "null ; Conference date: 28-06-2017 Through 30-06-2017",
    url = "http://www.ippapublicpolicy.org/conference/icpp-3-singapore-2017/7",

    }

    Instruments of Transformative Governance : Product Development Partnerships for Neglected Diseases. / Borrás, Susana.

    2017. Paper presented at 3rd International Conference on Public Policy, Singapore.

    Research output: Contribution to conferencePaperResearchpeer-review

    TY - CONF

    T1 - Instruments of Transformative Governance

    T2 - Product Development Partnerships for Neglected Diseases

    AU - Borrás,Susana

    PY - 2017

    Y1 - 2017

    N2 - Product Development Partnerships (PDPs) for neglected diseases bring different actors together aiming to provide accessible medicines for these complex diseases. Finding solutions requires advanced investments in R&D, expensive clinical trials, long medicine approval processes, and reliable drug production and distribution channels. PDPs aim at overcoming current market and government failures by pooling resources in the attempt to solve this global social challenge. Thus, PDPs are a case of instruments of transformative research and innovation, operating in a transnational governance context. They exhibit three novelties: they address strategic long-term problems in a holistic manner, set substantive output-oriented goals, and are implemented through new organizational structures. After characterizing the different types of current PDPs and the context in which they emerged, the paper examines in detail three cases of single- and multi-disease PDPs (DNDi, EVI, and MVI). The cases show that their functions have been evolving through time, as the PDPs are becoming more specialized and focused. Yet, their ability to mobilize the resources (funding, organizational, knowledge and legitimacy resources) to fulfill these functions depends largely on their capability as agents to adapt to changing opportunity structures.

    AB - Product Development Partnerships (PDPs) for neglected diseases bring different actors together aiming to provide accessible medicines for these complex diseases. Finding solutions requires advanced investments in R&D, expensive clinical trials, long medicine approval processes, and reliable drug production and distribution channels. PDPs aim at overcoming current market and government failures by pooling resources in the attempt to solve this global social challenge. Thus, PDPs are a case of instruments of transformative research and innovation, operating in a transnational governance context. They exhibit three novelties: they address strategic long-term problems in a holistic manner, set substantive output-oriented goals, and are implemented through new organizational structures. After characterizing the different types of current PDPs and the context in which they emerged, the paper examines in detail three cases of single- and multi-disease PDPs (DNDi, EVI, and MVI). The cases show that their functions have been evolving through time, as the PDPs are becoming more specialized and focused. Yet, their ability to mobilize the resources (funding, organizational, knowledge and legitimacy resources) to fulfill these functions depends largely on their capability as agents to adapt to changing opportunity structures.

    M3 - Paper

    ER -

    Borrás S. Instruments of Transformative Governance: Product Development Partnerships for Neglected Diseases. 2017. Paper presented at 3rd International Conference on Public Policy, Singapore.